Topics

Roche's personalized cancer treatment wins FDA approval

17:14 EDT 15 Aug 2019 | Reuters

The U.S. Food and Drug Administration approved Roche Holding AG's treatment for adult and adolescent patients whose cancers have a genetic defect, the agency said on Thursday.

Original Article: Roche's personalized cancer treatment wins FDA approval

NEXT ARTICLE

More From BioPortfolio on "Roche's personalized cancer treatment wins FDA approval"

Quick Search

Relevant Topic

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...